EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

Van Thien Chi Nguyen iD, Trong Hieu Nguyen, Nhu Nhat Tan Doan, Thi Mong Quynh Pham, Giang Thi Huong Nguyen iD, Thanh Dat Nguyen, Thuy Thi Thu Tran, Duy Long Vo, Thanh Hai Phan, Thanh Xuan Jasmine, Van Chu Nguyen, Huu Thinh Nguyen iD und 48 weitere

eLife · 11.10.2023 · 12

DOI: 10.7554/elife.89083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 11.10.2023. Verfasst von Van Thien Chi Nguyen und 59 weiteren Autor:innen. Beteiligte Einrichtung: Gene Solutions, Ho Chi Minh City, Viet Nam. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gene Solutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite their promise, circulating tumor DNA (ctDNA)-based assays for multi-cancer early detection face challenges in test performance, due mostly to the limited abundance of ctDNA and its inherent variability. To address these challenges, published assays to date demanded a very high-depth sequencing, resulting in an elevated price of test. Herein, we developed a multimodal assay called SPOT-MAS (screening for the presence of tumor by methylation and size) to simultaneously profile methylomics, fragmentomics, copy number, and end motifs in a single workflow using targeted and shallow genome-wide sequencing (~0.55×) of cell-free DNA. We applied SPOT-MAS to 738 non-metastatic patients with breast, colorectal, gastric, lung, and liver cancer, and 1550 healthy controls. We then employed machine learning to extract multiple cancer and tissue-specific signatures for detecting and locating cancer. SPOT-MAS successfully detected the five cancer types with a sensitivity of 72.4% at 97.0% specificity. The sensitivities for detecting early-stage cancers were 73.9% and 62.3% for stages I and II, respectively, increasing to 88.3% for non-metastatic stage IIIA. For tumor-of-origin, our assay achieved an accuracy of 0.7. Our study demonstrates comparable performance to other ctDNA-based assays while requiring significantly lower sequencing depth, making it economically feasible for population-wide screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNAEarly Detection of CancerNeoplasmsHumansBiomarkers, TumorCell-Free Nucleic AcidsDNA, NeoplasmLiver Neoplasms

Stichwörter der Autor:innen

cancer biologycirculating tumor DNAgeneticsgenomicshumanliquid biopsymultimodal analysis

Substanzen

Biomarkers, TumorCell-Free Nucleic AcidsCirculating Tumor DNADNA, Neoplasm

Autor:innen und Institutionen

  • Gene Solutions, Ho Chi Minh City, Viet Nam.
  • Medical Genetics Institute, Ho Chi Minh City, Viet Nam.
  • University Medical Center, Ho Chi Minh City, Viet Nam.
  • MEDIC Medical Center, Ho Chi Minh City, Viet Nam.
  • National Cancer Hospital, Hanoi, Viet Nam.
  • Hanoi Medical University, Hanoi, Viet Nam.

ORCID-Profile: Van Thien Chi Nguyen, Giang Thi Huong Nguyen, Huu Thinh Nguyen, Quang Thong Dang

Förderung

  • Gene Solutions

Zitieren

APA

Nguyen, V. T. C., Nguyen, T. H., Doan, N. N. T., Pham, T. M. Q., Nguyen, G. T. H., Nguyen, T. D., Tran, T. T. T., Vo, D. L., Phan, T. H., Jasmine, T. X., Nguyen, V. C., Nguyen, H. T., Nguyen, T. V., Nguyen, T. H. H., Huynh, L. A. K., Tran, T. H., Dang, Q. T., Doan, T. N., Tran, A. M., …, & Truong, D. K. (2023). Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization. eLife, 12. https://doi.org/10.7554/elife.89083

Vancouver

Nguyen VTC, Nguyen TH, Doan NNT, Pham TMQ, Nguyen GTH, Nguyen TD, et al. Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization. eLife. 2023;12. doi:10.7554/elife.89083

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Van Thien Chi and Nguyen, Trong Hieu and Doan, Nhu Nhat Tan and Pham, Thi Mong Quynh and Nguyen, Giang Thi Huong and Nguyen, Thanh Dat and Tran, Thuy Thi Thu and Vo, Duy Long and Phan, Thanh Hai and Jasmine, Thanh Xuan and Nguyen, Van Chu and Nguyen, Huu Thinh and Nguyen, Trieu Vu and Nguyen, Thi Hue Hanh and Huynh, Le Anh Khoa and Tran, Trung Hieu and Dang, Quang Thong and Doan, Thuy Nguyen and Tran, Anh Minh and Nguyen, Viet Hai and Nguyen, Vu Tuan Anh and Ho, Le Minh Quoc and Tran, Quang Dat and Pham, Thi Thu Thuy and Ho, Tan Dat and Nguyen, Bao Toan and Nguyen, Thanh Nhan Vo and Nguyen, Thanh Dang and Phu, Dung Thai Bieu and Phan, Boi Hoan Huu and Vo, Thi Loan and Nai, Thi Huong Thoang and Tran, Thuy Trang and Truong, My Hoang and Tran, Ngan Chau and Le, Trung Kien and Tran, Thanh Huong Thi and Duong, Minh Long and Bach, Hoai Phuong Thi and Kim, Van Vu and Pham, The Anh and Tran, Duc Huy and Le, Trinh Ngoc An and Pham, Truong Vinh Ngoc and Le, Minh Triet and Vo, Dac Ho and Tran, Thi Minh Thu and Nguyen, Minh Nguyen and Van, Thi Tuong Vi and Nguyen, Anh Nhu and Tran, Thi Trang and Tran, Vu Uyen and Le, Minh Phong and Do, Thi Thanh and Phan, Thi Van and Nguyen, Hong-Dang Luu and Nguyen, Duy Sinh and Cao, Van Thinh and Do, Thanh-Thuy Thi and Truong, Dinh Kiet},
  title = {Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.89083}
}
Kostenlos starten →